Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00568087 · ClinicalTrials.gov registry record · Phase 1
N-acetylcysteine in Alcohol Dependence
A Phase 1 study of Alcoholism, sponsored by Minneapolis Veterans Affairs Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT00568087 is a Phase 1 study of Alcoholism that has completed, run by Minneapolis Veterans Affairs Medical Center. The registered enrollment target is 46 participants, below the 374-participant average among 65 other Alcoholism trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00568087, a Phase 1 study of Alcoholism, has completed, sponsored by Minneapolis Veterans Affairs Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
The present study is designed to find out if N-acetylcysteine works in reducing alcohol drinking and craving.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG N-acetylcysteine
Study Locations (1)
Minnesota
- Minneapolis VA Medical Center - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2007-12 |
| Est. Completion | 2009-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00568087
The ClinicalTrials.gov registry entry for NCT00568087 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 374-participant average among 65 other Alcoholism trials with a reported enrollment target (88% lower). The listed sponsor is Minneapolis Veterans Affairs Medical Center, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Alcoholism appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00568087 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT00568087 about?
NCT00568087 is a clinical study titled "N-acetylcysteine in Alcohol Dependence". The present study is designed to find out if N-acetylcysteine works in reducing alcohol drinking and craving.
What is the current status of trial NCT00568087?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 46 participants. The study started on 2007-12. Estimated completion is 2009-08.
What conditions does trial NCT00568087 study?
This clinical trial studies the following conditions: Alcoholism.
What interventions are being tested in trial NCT00568087?
The interventions under investigation include: Placebo (DRUG), N-acetylcysteine (DRUG).
Who is sponsoring clinical trial NCT00568087?
This trial is sponsored by Minneapolis Veterans Affairs Medical Center, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00568087 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcoholism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence
COMPLETED · Phase 1
-
A Novel Compound for Alcoholism Treatment
COMPLETED · Phase 1
-
Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home
COMPLETED · Phase 1
-
GSK1521498 Alcohol Interaction Study
COMPLETED · Phase 1
-
Repurposing alpha1 Noradrenergic Antagonists for Alcoholism Treatment
COMPLETED · Phase 1
-
Matching Genotypes and Serotonergic Medications for Alcoholism
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.